1. Home
  2. FSUN vs PGEN Comparison

FSUN vs PGEN Comparison

Compare FSUN & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FSUN

FirstSun Capital Bancorp

HOLD

Current Price

$36.05

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.76

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSUN
PGEN
Founded
1892
1998
Country
United States
United States
Employees
1186
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
FSUN
PGEN
Price
$36.05
$4.76
Analyst Decision
Buy
Buy
Analyst Count
3
5
Target Price
$45.00
$8.33
AVG Volume (30 Days)
152.5K
4.9M
Earning Date
04-27-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$230,981,000.00
Revenue This Year
$79.34
$1,115.92
Revenue Next Year
$14.67
$81.04
P/E Ratio
$11.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.95
$1.40
52 Week High
$42.34
$5.47

Technical Indicators

Market Signals
Indicator
FSUN
PGEN
Relative Strength Index (RSI) 51.75 64.27
Support Level $34.32 $3.96
Resistance Level $37.12 $5.06
Average True Range (ATR) 0.94 0.29
MACD 0.09 0.10
Stochastic Oscillator 58.84 94.24

Price Performance

Historical Comparison
FSUN
PGEN

About FSUN FirstSun Capital Bancorp

Firstsun Capital Bancorp is the financial holding company. It provides a full range of deposit, lending, treasury management, wealth management, and online banking products and services. The company operates in two segments; Banking operations and mortgage operations, the majority of which are generated by the banking operations segment. The Banking segment originates loans and provides deposits and fee based services to consumer, business, and mortgage lending customers. Products offered include a full range of commercial and consumer banking and financial services. The Mortgage Operations segment originates, sells, services, and manages market risk from changes in interest rates on one-to-four family residential mortgage loans.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: